|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
5,280,000 |
Market
Cap: |
177.41(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$2.26 - $51.89 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Monopar Therapeutics is a biopharmaceutical company focused on developing proprietary therapeutics for cancer patients. Co.'s compounds in development: Validive®, a Phase 2b/3 clinical stage, mucoadhesive buccal tablet for the prevention of radiation induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin, a Phase 1b clinical stage analog of doxorubicin engineered specifically to retain anticancer activity while minimizing toxic effects on the heart; MNPR-101, a preclinical stage uPAR-targeted antibody being developed as a radioimmunotherapeutic and companion diagnostic for cancers and COVID-19; and an early stage camsirubicin analog, MNPR-202, for various cancers.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
1,550 |
130,058 |
Total Buy Value |
$0 |
$0 |
$25,188 |
$125,188 |
Total People Bought |
0 |
0 |
1 |
2 |
Total Buy Transactions |
0 |
0 |
1 |
11 |
Total Shares Sold |
33,334 |
33,334 |
33,334 |
33,334 |
Total Sell Value |
$1,166,690 |
$1,166,690 |
$1,166,690 |
$1,166,690 |
Total People Sold |
1 |
1 |
1 |
1 |
Total Sell Transactions |
1 |
1 |
1 |
1 |
End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mazar Andrew Paul |
Chief Executive OfficerMember |
|
2025-04-02 |
4 |
S |
$35.00 |
$1,166,690 |
D/D |
(33,334) |
822,255 |
|
13% |
|
Robinson Chandler |
Chief Executive Officer |
|
2025-03-31 |
4 |
D |
$36.41 |
$43,838 |
D/D |
(1,204) |
65,993 |
|
- |
|
Robinson Chandler |
Chief Executive Officer |
|
2025-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,106 |
67,197 |
|
- |
|
Cittadine Andrew |
Chief Operating Officer |
|
2025-03-31 |
4 |
D |
$36.41 |
$27,089 |
D/D |
(744) |
41,985 |
|
- |
|
Cittadine Andrew |
Chief Operating Officer |
|
2025-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,791 |
42,729 |
|
- |
|
Robinson Chandler |
Chief Executive Officer |
|
2025-03-04 |
4 |
D |
$31.70 |
$55,760 |
D/D |
(1,759) |
63,091 |
|
- |
|
Robinson Chandler |
Chief Executive Officer |
|
2025-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,002 |
64,850 |
|
- |
|
Talukdar Lavina |
Director |
|
2025-02-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,001 |
|
-17% |
|
Cittadine Andrew |
Chief Operating Officer |
|
2024-12-31 |
4 |
D |
$22.00 |
$15,862 |
D/D |
(721) |
40,938 |
|
- |
|
Cittadine Andrew |
Chief Operating Officer |
|
2024-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,790 |
41,659 |
|
- |
|
Robinson Chandler |
Chief Executive Officer |
|
2024-12-31 |
4 |
D |
$22.00 |
$48,598 |
D/D |
(2,209) |
58,848 |
|
- |
|
Robinson Chandler |
Chief Executive Officer |
|
2024-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,895 |
61,057 |
|
- |
|
Tacticgem Llc |
10% Owner |
|
2024-12-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,433,334) |
0 |
|
- |
|
Radhakrishnan Karthik |
Chief Financial Officer |
|
2024-10-28 |
4 |
B |
$16.25 |
$25,188 |
D/D |
1,550 |
1,550 |
2.74 |
64% |
|
Robinson Chandler |
Chief Executive Officer |
|
2024-09-30 |
4 |
D |
$6.74 |
$12,927 |
D/D |
(1,918) |
56,162 |
|
- |
|
Robinson Chandler |
Chief Executive Officer |
|
2024-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,895 |
58,080 |
|
- |
|
Cittadine Andrew |
Chief Operating Officer |
|
2024-09-30 |
4 |
D |
$6.74 |
$3,606 |
D/D |
(535) |
39,869 |
|
- |
|
Cittadine Andrew |
Chief Operating Officer |
|
2024-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,791 |
40,404 |
|
- |
|
Tsuchimoto Kim R |
Chief Financial Officer |
|
2024-06-30 |
4 |
D |
$0.73 |
$2,192 |
D/D |
(2,998) |
57,429 |
|
- |
|
Tsuchimoto Kim R |
Chief Financial Officer |
|
2024-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,957 |
60,427 |
|
- |
|
Robinson Chandler |
Chief Executive Officer |
|
2024-06-30 |
4 |
D |
$0.73 |
$6,348 |
D/D |
(8,684) |
265,923 |
|
- |
|
Robinson Chandler |
Chief Executive Officer |
|
2024-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,476 |
274,607 |
|
- |
|
Cittadine Andrew |
Chief Operating Officer |
|
2024-06-30 |
4 |
D |
$0.73 |
$1,476 |
D/D |
(2,019) |
193,065 |
|
- |
|
Cittadine Andrew |
Chief Operating Officer |
|
2024-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,952 |
195,084 |
|
- |
|
Cittadine Andrew |
Chief Operating Officer |
|
2024-06-20 |
4 |
B |
$0.74 |
$15,254 |
D/D |
20,508 |
186,132 |
2.74 |
381% |
|
190 Records found
|
|
Page 1 of 8 |
|
|